Staphylococcus Aureus Clinical Trial
Official title:
Clinical Priority Program: Bone Infection; Use of a Registry on Infection to Improve Patient Outcomes and Research Efforts
Establish an international registry of over 400 patients with deep infections involving the
bone and/or joint from≥20 centers representing all regions of the world with varied hospital
and surgeon practice settings to ensure that registry analyses and research reflect typical
clinical practice thereby providing optimal guidance for patients, clinicians, and healthcare
researchers. Using a data collection platform that minimizes entry burden, collects most
information at the time of surgery, and uses Internet technology to minimize data entry. The
registry will include:
1. baseline patient attributes;
2. surgical approach, implants and technology;
3. hospital course;
4. surgeon and institutional characteristics;
5. longitudinal patient outcome,
6. post-procedure complications and revisions,
7. serum/tissue/drainage samples.
Establish an international registry with AOCID of over 400 patients with deep infections
involving the bone and/or joint from ≥ 20 centers representing all regions of the world with
varied hospital and surgeon practice settings to ensure that registry analyses and research
reflect typical clinical practice thereby providing optimal guidance for patients,
clinicians, and healthcare researchers. Creation of an AOCID Registry for musculoskeletal
infection cases will permit better analysis of the causes, contributing factors including
patient immune responses, treatments and clinical outcomes of musculoskeletal infections.
- Establish a practice network that includes ≥ 20 geographically distributed centers.
These busy practices will be treating patients with varied geographic status to assure
balanced representation of diverse patients and practices.
- Establish a Data Coordinating Core team with AOCID using a data collection platform that
minimizes entry burden, collects most information at the time of surgery, and uses
Internet technology to minimize data entry.
The registry will include:
- baseline patient attributes
- surgical approach, implants and technology
- hospital course
- surgeon and institutional characteristics
- longitudinal patient outcome
- post-procedure complications and revisions
- serum/tissue/drainage samples
- Establish a Statistical Support team with AOCID to implement cutting-edge
statistical techniques including the use of hierarchical generalized linear latent
and mixed effects models to address the complex structure and longitudinal nature
of registry data. Multivariable predictive models for outcome(s) of infection will
be developed.
- Establish an Outcomes Measurement Team with AOCID and Investigators from the CPP
team to advance the science of infection-specific and global patient-reported
outcomes to support efficient data collection of web-based, longitudinal data in
this registry and future comparative effectiveness research.
- Develop new assessment tools and conduct research useful to clinical practice.
Establish consensus on the definition of treatment failure- characterized as lack
of clinically meaningful improvement in infection, pain or physical function
following treatment, validate, and refine prediction algorithms for patients at
risk for failure.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05073926 -
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
|
||
Completed |
NCT01212120 -
The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections
|
N/A | |
Completed |
NCT00801879 -
Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
|
Phase 4 | |
Terminated |
NCT03638947 -
Reducing Perioperative S. Aureus Transmission
|
N/A | |
Recruiting |
NCT05331885 -
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
|
Phase 3 | |
Recruiting |
NCT05094570 -
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
|
Phase 4 | |
Not yet recruiting |
NCT05092464 -
Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic Dermatitis
|
N/A | |
Recruiting |
NCT05695196 -
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
|
Phase 1 | |
Enrolling by invitation |
NCT04666532 -
S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
|
||
Active, not recruiting |
NCT02572791 -
Staph Household Intervention for Eradication (SHINE)
|
Phase 4 | |
Recruiting |
NCT04274348 -
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
|
N/A | |
Enrolling by invitation |
NCT05880069 -
Clinical Outcomes in Patients With Infection by Resistant Microorganism
|
||
Completed |
NCT01011335 -
Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial
|
Phase 1/Phase 2 | |
Completed |
NCT03816956 -
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
|
Phase 3 | |
Not yet recruiting |
NCT04884958 -
A Study to Investigate the Transmission and Burden of PVL-MRSA in Households in Sri Lanka
|
||
Completed |
NCT01105767 -
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
|
N/A | |
Completed |
NCT00475930 -
Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
|
N/A | |
Completed |
NCT00507247 -
Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
|
Phase 2 | |
Recruiting |
NCT03220386 -
Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus (MSSA/MRSA) - Point-of-care-testing (POCT) in Clinical Decision Making
|
N/A | |
Completed |
NCT03140423 -
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
|
Phase 4 |